Logo image
A new high-prevalence LW antigen detected by an antibody in an Indigenous Australian homozygous for LWA c.309C>A variant
Journal article   Peer reviewed

A new high-prevalence LW antigen detected by an antibody in an Indigenous Australian homozygous for LWA c.309C>A variant

Genghis H Lopez, Brett Wilson, Glenda M Millard, Tanya L Cawthorne, Dianne E Grey, Elizabeth A Fong, Robert L Flower, Catherine A Hyland and Yew-Wah Liew
Vox Sanguinis, Vol.117(7), pp.958-965
2022
PMID: 35412682
url
https://doi.org/10.1111/vox.13276View
Published Version

Abstract

LWEM Indigenous Australian LW high-prevalence antigen LW8 GenBank MN412704 LW blood group system LW*A c.309C>A polymorphism UniSC Diversity Area - Aboriginal and Torres Strait Islander Engagement
Background and objectives: The LW gene encodes the LW glycoprotein that carries the antigens of the LW blood group system. LW antigens are distinct from D antigen, however, they are phenotypically related and anti-LW antibodies are often mistaken as anti-D. An antibody was detected in an Australian patient of Aboriginal descent who consistently typed as LW(a+b-). This study aimed to describe the antibody recognizing a high-prevalence antigen on the LW glycoprotein. Study design and methods: Samples from the patient and her four siblings were investigated. DNA was genotyped by single nucleotide polymorphism (SNP)-microarray and massively parallel sequencing (MPS) platforms. Red blood cells (RBCs) were phenotyped using standard haemagglutination techniques. Antibody investigations were performed using a panel of phenotyped RBCs from adults and cord blood cells. Results: SNP-microarray and MPS genotyped all family members as LW*A/A, (c.299A), predicting LW(a+b-). In addition, a novel LW*A c.309C>A single nucleotide variant was detected in all family members. The patient and one of her siblings (M4) were LW c.309C>A homozygous. Antibody from the patient reacted positive to all reagent panel RBCs and cord blood cells but negative with RBCs from LW(a-b-), Rhnull and sibling M4. Antibody failed to react with RBCs treated with dithiothreitol. Conclusion: Antibody detected in the patient recognized a novel high-prevalence antigen, LWEM, in the LW blood group system. LWEM-negative patients who developed anti-LWEM can be safely transfused with D+ RBCs, however, D- is preferred. Accurate antibody identification can help better manage allocation of blood products especially when D- RBCs are in short supply.

Details

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Web Of Science research areas
Hematology

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: SDGs from InCites

Logo image